Previously, it was found that patients with stroke showed an increase in number of early-stage BCAS1+ oligodendrocytes, but not in late-stage BCAS1+ oligodendrocytes, compared to control donors without CNS pathology (20). The gene discussed is BCAS1; the disease is stroke disorder.